Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection

Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection

Hepatitis B surface antigen (HBsAg) has recently gained traction as a biomarker that may provide prognostic information and inform treatment decisions in chronic hepatitis B virus (HBV) infection. It may be particularly useful when HBV DNA levels are low and therefore difficult to quantify accuratel...

Full description

Bibliographic Details
Main Authors:	Downs, L, Patel, M, Ansari, M, McNaughton, A, Smith, D, Andersson, M, Barnes, E, Jeffery, K, Matthews, P
Format:	Conference item
Published:	Elsevier 2018

Similar Items

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
by: Shaowen Jiang, et al.
Published: (2023-01-01)

Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients
by: Hui Liu, et al.
Published: (2024-04-01)

Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.
by: Edouard Tuaillon, et al.
Published: (2012-01-01)

Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection
by: Downs, L, et al.
Published: (2019)

Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01)

Solely HBsAg intrauterine exposure accelerates HBV clearance by promoting HBs-specific immune response in the mouse pups
by: Jing Ning, et al.
Published: (2022-12-01)

Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
by: Louise O. Downs, et al.
Published: (2019-06-01)

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition In Vitro
by: Romina Salpini, et al.
Published: (2020-02-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
by: Xin Liu, et al.
Published: (2023-08-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
by: Anouar Teriaky, et al.
Published: (2013-01-01)

Characteristics of HBcrAg in HBsAg-/HBV DNA+ blood donors in Wuxi area
by: Yan WANG, et al.
Published: (2024-01-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Serological and molecular characterization of HBV infection with HBsAg reactive and HBV DNA non-reactive
by: Chunxiang LI, et al.
Published: (2022-09-01)

ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
by: Wen-Han Yu, et al.
Published: (2018-02-01)

Is Quantitative HBsAg Measurement a Reliable Substitute for HBV DNA Quantitation?
by: Mohammad Reza Mahdavi, et al.
Published: (2015-07-01)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
by: Carlotta Cerva, et al.
Published: (2022-02-01)

Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
by: Xian-ding Wang, et al.
Published: (2021-01-01)

Role of HBsAg Neutralisation Test in Low Positive and Indeterminate HBsAg Results by Electrochemiluminescence
by: Mridula Madiyal, et al.
Published: (2024-03-01)

Comparative assessment of immunochromatography and ELISA diagnostic tests for HBsAg detection in PCR-confirmed HBV infection
by: N. Navvabi, et al.
Published: (2022-04-01)

Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy
by: Muye Xia, et al.
Published: (2025-02-01)

Concurrent presence of HBsAg and anti-HBs in children
by: H Ozen, et al.
Published: (2000-07-01)

Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
Published: (2011-12-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Serological characteristics of HBsAg positive/HBV DNA non-reactive blood donors
by: Yuanyuan JING, et al.
Published: (2024-04-01)

In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
by: Robert L. Kruse, et al.
Published: (2017-12-01)

Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection?
by: Akif Altinbas, et al.
Published: (2012-05-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report
by: Maki Ohkubo, et al.
Published: (2023-12-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
by: Crozier Sarah, et al.
Published: (2008-04-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
by: Michel Bazinet, et al.
Published: (2022-08-01)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
by: Ying Wang, et al.
Published: (2021-11-01)

Comparative analysis of the safety and efficacy of HBsAg-1018 versus HBsAg-Eng: a meta-analysis
by: Lin Zhang, et al.
Published: (2020-01-01)

B cells were related to HBsAg seroconversion in inactive HBsAg carriers following peginterferon therapy.
by: Zhenhuan Cao, et al.
Published: (2020-01-01)

IL-10 Promoter Polymorphism Distribution among HBsAg-Reactive and HBsAg-Nonreactive Blood Donors
by: Rahmat Azhari Kemal, et al.
Published: (2020-03-01)

Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy
by: Zhenhuan Cao, et al.
Published: (2020-10-01)

Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies
by: Tai-Cheng Zhou, et al.
Published: (2017-04-01)

What are the causes and outcomes of the coexistence of HBsAg and anti-HBs?
by: Murat Afyon
Published: (2016-05-01)